Apellis Pharmaceuticals

-$1.17 (-1.75%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product.

CEO

Cedric Francois

Employees

374

Headquarters

Waltham, Massachusetts

Founded

2009

APLS Key Statistics

Market Cap

5.28B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

948.96K

High Today

$67.12

Low Today

$64.85

Open Price

$66.97

Volume

686.09K

52 Week High

$73.00

52 Week Low

$25.49

Analyst Ratings

88%

of 16 ratings

Buy

87.5%

Hold

12.5%

Sell

APLS Earnings

-$2.32

-$1.24

-$0.15

$0.93

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 6, Pre-Market